299 related articles for article (PubMed ID: 34870709)
1. Clinical significance and biological functions of chemokine CXCL3 in head and neck squamous cell carcinoma.
Guan J; Weng J; Ren Q; Zhang C; Hu L; Deng W; Lu S; Dong X; Li W; Li Y; Wang W
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34870709
[TBL] [Abstract][Full Text] [Related]
2. CXCL3 overexpression affects the malignant behavior of oral squamous cell carcinoma cells via the MAPK signaling pathway.
Weng J; Ren Q; Li Z; Wang W; Guan J
J Oral Pathol Med; 2021 Oct; 50(9):902-910. PubMed ID: 34392586
[TBL] [Abstract][Full Text] [Related]
3. Identification of CCT3 as a prognostic factor and correlates with cell survival and invasion of head and neck squamous cell carcinoma.
Wang Y; Liu P; Zhang Z; Wang J; Cheng Z; Fan C
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34505628
[TBL] [Abstract][Full Text] [Related]
4. Aberrant overexpression of transcription factor Forkhead box D1 predicts poor prognosis and promotes cancer progression in HNSCC.
Li J; Yan T; Wu X; Ke X; Li X; Zhu Y; Yang J; Li Z
BMC Cancer; 2021 Nov; 21(1):1205. PubMed ID: 34772357
[TBL] [Abstract][Full Text] [Related]
5. G-Protein-Coupled Receptor Kinase-Interacting Protein 1 (GIT1) Promotes Head and Neck Squamous Cell Carcinoma Metastases via Activating the PI3K/AKT/mTOR Signal Pathway.
Xu R; Xu R; Wang Y; Wang W; Jiang L; Gong S
Comput Math Methods Med; 2022; 2022():6881932. PubMed ID: 35116073
[TBL] [Abstract][Full Text] [Related]
6. ETV5 facilitates tumor progression in head-neck squamous cell carcinoma.
Yu S; Ma Z; Chen T; Wang H; Yao Q; Li J; Cheng J
Oral Dis; 2024 May; 30(4):2004-2017. PubMed ID: 37649213
[TBL] [Abstract][Full Text] [Related]
7. CXCL3 overexpression promotes the tumorigenic potential of uterine cervical cancer cells via the MAPK/ERK pathway.
Qi YL; Li Y; Man XX; Sui HY; Zhao XL; Zhang PX; Qu XS; Zhang H; Wang BX; Li J; Qi SF; Jia LL; Luan HY; Zhang CB; Wang WQ
J Cell Physiol; 2020 May; 235(5):4756-4765. PubMed ID: 31667838
[TBL] [Abstract][Full Text] [Related]
8. CDX2 enhances natural killer cell-mediated immunotherapy against head and neck squamous cell carcinoma through up-regulating CXCL14.
Wang H; Nan S; Wang Y; Xu C
J Cell Mol Med; 2021 May; 25(10):4596-4607. PubMed ID: 33733587
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of CXCL3 in colon cancer promotes malignant behaviors of tumor cells in an ERK-dependent manner.
Cheng Y; Yang X; Liang L; Xin H; Dong X; Li W; Li J; Guo X; Li Y; He J; Zhang C; Wang W
BMC Cancer; 2023 Nov; 23(1):1162. PubMed ID: 38031087
[TBL] [Abstract][Full Text] [Related]
10. P4HA2 contributes to head and neck squamous cell carcinoma progression and EMT through PI3K/AKT signaling pathway.
Wu YL; Liu W; Zhao T; Jin J
Med Oncol; 2024 May; 41(6):163. PubMed ID: 38777998
[TBL] [Abstract][Full Text] [Related]
11. Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.
Chen L; He X; Yi S; Liu G; Liu Y; Ling Y
Biomed Res Int; 2021; 2021():8824195. PubMed ID: 33628816
[TBL] [Abstract][Full Text] [Related]
12. Elevated RUNX1 is a prognostic biomarker for human head and neck squamous cell carcinoma.
Feng X; Zheng Z; Wang Y; Song G; Wang L; Zhang Z; Zhao J; Wang Q; Lun L
Exp Biol Med (Maywood); 2021 Mar; 246(5):538-546. PubMed ID: 33241710
[TBL] [Abstract][Full Text] [Related]
13. Targeting of EZH2 inhibits epithelial‑mesenchymal transition in head and neck squamous cell carcinoma via regulating the STAT3/VEGFR2 axis.
Zhao M; Hu X; Xu Y; Wu C; Chen J; Ren Y; Kong L; Sun S; Zhang L; Jin R; Zhou X
Int J Oncol; 2019 Nov; 55(5):1165-1175. PubMed ID: 31545422
[TBL] [Abstract][Full Text] [Related]
14. LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus.
Jiang Y; Cao W; Wu K; Qin X; Wang X; Li Y; Yu B; Zhang Z; Wang X; Yan M; Xu Q; Zhang J; Chen W
J Exp Clin Cancer Res; 2019 Aug; 38(1):365. PubMed ID: 31429766
[TBL] [Abstract][Full Text] [Related]
15. Rh type C-glycoprotein functions as a novel tumor suppressor gene by inhibiting tumorigenicity and metastasis in head and neck squamous cell carcinoma.
Xu W; Zou H; Wei Z; Song C; Tang C; Yin X; Wang Y; Han S; Cai Y; Han W
Aging (Albany NY); 2019 Jun; 11(11):3601-3623. PubMed ID: 31170090
[TBL] [Abstract][Full Text] [Related]
16. CD147 promotes progression of head and neck squamous cell carcinoma via NF-kappa B signaling.
Yu B; Zhang Y; Wu K; Wang L; Jiang Y; Chen W; Yan M
J Cell Mol Med; 2019 Feb; 23(2):954-966. PubMed ID: 30421493
[TBL] [Abstract][Full Text] [Related]
17. USP39 Promotes the Viability and Migration of Head and Neck Squamous Cell Carcinoma Cell by Regulating STAT1.
Hu Y; Wang Y; Hu W; Hu C; Wang B; Liu C; Deng A; Shen B; Wu K; Liu Y
Technol Cancer Res Treat; 2024; 23():15330338241250298. PubMed ID: 38706215
[No Abstract] [Full Text] [Related]
18. Prognostic role of DFNA5 in head and neck squamous cell carcinoma revealed by systematic expression analysis.
Liu Z; Liu H; Dong Q; Li H; Zhang B; Liu Y; Zhong L; Tang H
BMC Cancer; 2021 Aug; 21(1):951. PubMed ID: 34433433
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
[TBL] [Abstract][Full Text] [Related]
20. Identification of
Tanaka N; Minemura C; Asai S; Kikkawa N; Kinoshita T; Oshima S; Koma A; Kasamatsu A; Hanazawa T; Uzawa K; Seki N
Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]